Zhang, P., Zhang, M., Liu, J., Zhou, Z., Zhang, L., Luo, P., Zhang, Z.

Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma

31 de July de 2025 by Zhang, P., Zhang, M., Liu, J., Zhou, Z., Zhang, L., Luo, P., Zhang, Z.

Background
Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer. Although immune checkpoint inhibitors (ICIs) have brought new treatment options for advanced patients, a considerable proportion still shows limited respon…